While BAP1 has been suggested as a negative prognostic factor in CCA, the available literature remains inconclusive, with conflicting studies reporting no clear impact of BAP1 mutations on OS and PFS [199,200]. The gene discussed is BAP1; the disease is cholangiocarcinoma.